Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatar-Directed Chemotherapy in Platinum-Resistant Ovarian Cancer
NCT02312245Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2015
- Primary completion
- Apr 2023
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, gemcitabine, pegylated liposomal doxorubicin, topotecan liposome, bevacizumab in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Mayo Clinic. Started Jul 2015; status: completed.
02
Drugs
Paclitaxel Micelles for Injectiongemcitabinepegylated liposomal doxorubicintopotecan liposomebevacizumab
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT02312245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312245.